Volatolomic signatures of anaplastic lymphoma kinase gene rearrangement in adenocarcinoma

被引:0
|
作者
Hida, T. [1 ]
Oya, Y. [1 ]
Tanaka, K. [1 ]
Yoshida, T. [1 ]
Shimizu, J. [1 ]
Horio, Y. [1 ]
Yatabe, Y. [2 ]
Itoh, T. [3 ]
Shin, W. [3 ]
机构
[1] Aichi Canc Ctr Hosp, Thorac Oncol, Nagoya, Aichi, Japan
[2] Aichi Canc Ctr Hosp, Pathol & Mol Diagnost, Nagoya, Aichi, Japan
[3] Natl Inst Adv Ind Sci & Technol, Mat & Chem, Nagoya, Aichi, Japan
关键词
D O I
10.1016/S1556-0864(16)30126-5
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
12P
引用
收藏
页码:S61 / S61
页数:1
相关论文
共 50 条
  • [41] Destaining of Diff-Quik stained cytologic smears is not necessary for the detection of anaplastic lymphoma kinase gene rearrangement in lung adenocarcinoma by fluorescence in situ hybridization
    Xu, Weisheng
    Khurana, Kamal K.
    Tull, Jamie
    Maciak, Charlene
    Zhang, Shengle
    JOURNAL OF CYTOLOGY, 2016, 33 (03) : 154 - 158
  • [42] Pulmonary Spindle Cell Carcinoma Presenting Anaplastic Lymphoma Kinase Rearrangement
    Sonehara, Kei
    Nozawa, Shuhei
    Suzuki, Yusuke
    Araki, Taisuke
    Komatsu, Masamichi
    Tateishi, Kazunari
    Hanaoka, Masayuki
    CASE REPORTS IN ONCOLOGY, 2023, 16 (01): : 939 - 945
  • [43] Esophagitis resulting from treatment with crizotinib for anaplastic lymphoma kinase rearrangement-positive lung adenocarcinoma: A case report
    Takakuwa, Osamu
    Oguri, Tetsuya
    Yokoyama, Midori
    Hijikata, Hisatoshi
    Uemura, Takehiro
    Ohkubo, Hirotsugu
    Maeno, Ken
    Niimi, Akio
    MOLECULAR AND CLINICAL ONCOLOGY, 2014, 2 (01) : 121 - 123
  • [44] Poor response to gefitinib in lung adenocarcinoma with concomitant epidermal growth factor receptor mutation and anaplastic lymphoma kinase rearrangement
    Zhou, Jianya
    Zheng, Jing
    Zhao, Jing
    Sheng, Yihong
    Ding, Wei
    Zhou, Jianying
    THORACIC CANCER, 2015, 6 (02) : 216 - 219
  • [45] Evaluation of immunohistochemistry using two different antibodies and procedures for primary lung adenocarcinoma harboring anaplastic lymphoma kinase rearrangement
    Akiba, Jun
    Kawahara, Akihiko
    Abe, Hideyuki
    Azuma, Koichi
    Yamaguchi, Tomohiko
    Taira, Tomoki
    Fukumitsu, Chihiro
    Takase, Yorihiko
    Yasumoto, Makiko
    Umeno, Yumi
    Todoroki, Keita
    Kurita, Takashi
    Yamaguchi, Rin
    Kage, Masayoshi
    Yano, Hirohisa
    ONCOLOGY LETTERS, 2014, 8 (05) : 2155 - 2159
  • [46] Lung Adenocarcinoma with Anaplastic Lymphoma Kinase (ALK) Rearrangement Presenting as Carcinoma of Unknown Primary Site: Recognition and Treatment Implications
    Hainsworth J.D.
    Anthony Greco F.
    Drugs - Real World Outcomes, 2016, 3 (1) : 115 - 120
  • [47] Volatolomic Signatures to Assess Sensitivity to FGFR Tyrosine Kinase Inhibitors
    Kwon, Regina
    Barash, Orna
    Kayal, Haneen
    Rozeboom, Leslie
    Courthod, Giulia
    Kowalewski, Ashley A.
    Rivard, Christopher J.
    Rikke, Brad
    Peled, Nir
    Haick, Hossam
    Hirsch, Fred R.
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S490 - S491
  • [48] Anaplastic Lymphoma Kinase Gene Analysis as a Useful Tool for Identifying Primary Unknown Metastatic Lung Adenocarcinoma
    Watanabe, Naoki
    Ishii, Tomoya
    Takahama, Takayuki
    Tadokoro, Akira
    Kanaji, Nobuhiro
    Dobashi, Hiroaki
    Bandoh, Shuji
    INTERNAL MEDICINE, 2014, 53 (23) : 2711 - 2715
  • [49] Cytomorphology of Non-Small Cell Lung Carcinoma (NSCLC) with Anaplastic Lymphoma Kinase (ALK) Gene Rearrangement
    Toll, A. D.
    Illei, P.
    Maleki, Z.
    MODERN PATHOLOGY, 2013, 26 : 104A - 104A
  • [50] Neoadjuvant Crizotinib and Surgical Resection of Two Stage IIIA Lung Adenocarcinomas with Anaplastic Lymphoma Kinase Gene Rearrangement
    Li, Shaolei
    Yang, Yue
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S531 - S531